Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase

Pharmacology and Therapeutics

Volumn 78, Issue 1, 1998, Pages 29-46

  Gale Jr , Michael ^a   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Inhibitor; Interferons; PKR; Protein kinase; Translational control; Virus

Indexed keywords

INTERFERON; PROTEIN KINASE; VIRUS PROTEIN; VIRUS RNA;

ADENOVIRUS; ANTIVIRAL ACTIVITY; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIMIAN VIRUS; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; EIF-2 KINASE; HUMANS; INTERFERONS; PROTEIN BIOSYNTHESIS; VIRAL PROTEINS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 0345164384     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00165-4     Document Type: Review

References (211)

1. Agy M. B., Wambach M., Foy K., Katze M. G. Expression of cellular genes in CD4-positive lymphoid cells infected by the human immunodeficiency virus, HIV-1. evidence for a host protein synthesis shutoff induced by cellular mRNA degradation Virology. 177:1990;251-258.
2. Agy M. B., Acker R. L., Sherbert C. H., Katze M. G. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cells by distinct mechanisms. evidence for decreased stability and aberrant processing of HIV-1 proteins Virology. 214:1995;379-386.
3. Akkaraju G. R., Whitaker-Dowling P., Youngner J. S. Y., Jagus R. Specific kinase inhibitory factor of vaccinia virus prevents translational inhibition in rabbit reticulocytes. J. Biol. Chem. 264:1989;10321-10325.
4. Alfieri C., Birkenbach M., Kief E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 181:1991;595-608.
5. Alonso-Caplen F. V., Nemeroff M. E., Qiu Y., Krug R. M. Nucleocytoplasmic transport. the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA Genes Dev. 6:1992;255-267.
6. Alter M. Epidemiology of hepatitis C in the west. Semin. Liver Dis. 15:1995;5-14.
7. Baier L. J., Shors T., Shors S. T., Jacobs B. L. The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR. Nucl. Acids Res. 21:1993;4830-4835.
8. Barber G. N., Tomita J., Hovanessian A. G., Meurs E., Katze M. G. Functional expression and characterization of the interferon-induced double-stranded RNA activated P68 protein kinase from Escherichia coli. Biochemistry. 30:1991;10356-10361.
9. r protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;4621-4625.
10. Barber, G. N., Agy, M. B. and Katze, M. G. (1994) Regulation of viral and cellular gene expression in cells infected by animal viruses, including influenza virus and human immunodeficiency virus type 1. In: Methods in Virology, pp. 141-168. Adolph, K. (ed.) Academic Press, Inc., Orlando.
11. Barber G. N., Wambach M., Thompson S., Jagus R., Katze M. G. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol. 15:1995;3138-3146.
12. Beattie E., Tartaglia J., Paoletti E. Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology. 183:1991;419-422.
13. Beattie E., Denzler K. L., Tartaglia J., Perkus M. E., Paoletti E., Jacobs B. L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:1995;499-505. a.
14. - mutant viruses. Virology. 210:1995;254-263. b.
15. Beattie E., Kauffman E. B., Martinez H., Perkus M. E., Jacobs B. L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes. 12:1996;89-94.
16. Benkirane M., Neuveut C., Chun R. F., Smith S. M., Samuel C. E., Gatignol A., Jeang K.-T. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16:1997;611-624.
17. Berry M. J., Knutson G. S., Lasky S. R., Munemitsu S. M., Samuel C. E. Mechanism of interferon action. purification and substrate specificities of the double-stranded RNA dependent protein kinase from untreated and interferon-treated mouse fibroblasts J. Biol. Chem. 260:1985;11240-11247.
18. Bhat R. A., Thimmappaya B. Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc. Natl. Acad. Sci. USA. 80:1983;4789-4793.
19. Bhat R. A., Thimmappaya B. Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J. Virol. 56:1985;750-756.
20. n-dependent endonucleases of different molecular mass. Eur. J. Biochem. 179:1989;595-602.
21. r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection. implications for translational regulation J. Virol. 63:1989;2244-2252.
22. r protein kinase by poliovirus requires RNA. J. Virol. 67:1993;791-800.
23. Brand S. R., Kobayashi R., Mathews M. B. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272:1997;8388-8395.
24. Carpick B. W., Graziano V., Schneider D., Maitra R. K., Lee X., Williams B. R. G. Characterization of the solution structure between the interferon-induced double-stranded RNA-activated protein kinase and HIV-1 transactivating region RNA. J. Biol. Chem. 272:1997;9510-9516.
25. Carroll K., Elroy-Stein O., Moss R., Jagus R. Recombinant vaccinia virus K3L gene product prevents activation of dsRNA dependent eIF 2 kinase. J. Biol. Chem. 268:1993;12837-12842.
26. Chang H.-W., Jacobs B. L. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology. 194:1993;537-547.
27. Chang H.-W., Watson J. C., Jacobs B. L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon induced, dsRNA dependent protein kinase. Proc. Natl. Acad. Sci. USA. 89:1992;4825-4829.
28. Chee M., Yang R., Hubbell E., Berno A., Huang X.-H. C., Stern D., Winkler J., Lockhart D. J., Morris M. S., Fodor S. P. A. Accessing genetic information with high-density DNA arrays. Science. 274:1996;610-614.
29. Chen J.-J., London I. M. Regulation of protein synthesis by heme-regulated eIF-2α kinase. Trends Biochem. Sci. 20:1995;105-108.
30. Chen J., Pal J., Throop M. S., Gehrke L., Kuo I., Pal J. K., Brodsky M., London I. M. Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2α (eIF-2α) kinase of rabbit reticulocytes. homology to yeast GCN2 protein kinase and human double-stranded-RNA-dependent eIF-2α kinase Proc. Natl. Acad. Sci. USA. 88:1991;7729-7733.
31. Chong K. L., Schappert K., Meurs E., Feng F., Donahue T. F., Friesen J. D., Hovanessian A. G., Williams B. R. G. Human P68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11:1992;1553-1562.
32. Chou J., Roizman B. The γ34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA. 89:1992;3266-3270.
33. Clarke P. A., Sharp N. A., Clemens M. J. Translation control by the Epstein-Barr virus small RNA EBER-1. reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates Eur. J. Biochem. 193:1990;635-641.
34. Clarke P. A., Schwemmle M., Schickinger J., Hilse K., Clemens M. J. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-induced inhibitor of protein synthesis in reticulocyte lysates. Nucl. Acids Res. 19:1991;243-248.
35. Clemens M. J. The small RNAs of Epstein-Barr virus. Mol. Biol. Rep. 17:1993;81-92.
36. Clemens, M. J. (1996) Protein kinases that phosphorylate eIF-2 and eIF-2B, and their role in eukaryotic cell translational control. In: Translational Control, pp. 139-172. Hershey, J., Mathews, M. B. and Sonenberg, N. (eds.) Cold Spring Harbor Press, Cold Spring Harbor.
37. Clemens, M. J. and Elia, A. (1997) The double-stranded RNA-dependent protein kinase PKR - structure and function. J. Interferon Cytokine Res., in press.
38. Clemens M. J., Hershey J. W. B., Hovanessian A. G., Jacobs B. L., Katze M. G., Kaufman R. J., Lengyel P., Samuel C. E., Sen G. C., Williams B. R. G. PKR. proposed nomenclature for the RNA-dependent protein kinase induced by interferon J. Interferon Res. 13:1993;241.
39. Clemens M. J., Laing K. G., Jeffrey I. W., Schofield A., Sharp T. V., Elia A., Matys V., James M. C., Tilleray V. J. Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs. Biochimie. 76:1994;770-778.
40. Coccia E. M., Krust B., Hovanessian A. G. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J. Biol. Chem. 269:1994;23087-23094.
41. Colby C., Duesberg P. H. Double-stranded RNA in vaccinia virus infected cells. Nature. 222:1969;940-944.
42. Cosentino G. P., Venkatesan S., Serluca F. C., Green S. R., Mathews M. B., Sonenberg N. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9445-9449.
43. Craig A. W., Cosentino G. P., Donze O., Sonenberg N. The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J. Biol. Chem. 271:1996;24526-24533.
44. Craig E. A., Gambill B. D., Nelson R. J. Heat shock proteins. molecular chaperones of protein biogenesis Microbiol. Rev. 57:1993;402-414.
45. Danis C., Lemay G. Protein synthesis in different cell lines infected with orthoreovirus serotype 3. inhibition of host-cell protein synthesis correlates with accelerated viral multiplication and cell killing Biochem. Cell Biol. 71:1993;81-85.
46. Davies M. V., Elroy-Stein O., Jagus R., Moss B., Kaufman R. J. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66:1992;1943-1950.
47. Davies M. V., Chang H.-W., Jacobs B. L., Kaufman R. J. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA dependent protein kinase by different mechanisms. J. Virol. 67:1993;1688-1692.
48. Davis S., Watson J. C. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3' untranslated regions of human alpha-tropomyosin. Proc. Natl. Acad. Sci. USA. 93:1996;508-513.
49. Denzler K. L., Jacobs B. L. Site-directed mutagenic analysis of reovirus σ3 protein binding to dsRNA. Virology. 204:1994;190-199.
50. Der S. D., Yang Y. L., Weissman C., Williams B. R. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;3279-3283.
51. Dever T. E., Feng L., Wek R. C., Cigan A. M., Donahue T. F., Hinnebusch A. G. Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene specific translational control of GCN4 in yeast. Cell. 68:1992;585-596.
52. Dever T. E., Chen J.-J., Barber G. N., Cigan A. M., Feng L., Donahue T. F., London I., Katze M. G., Hinnebusch A. G. Mammalian eukaryotic initiation factor elF2α kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism in yeast. Proc. Natl. Acad. Sci. USA. 90:1994;4616-4620.
53. Easterbrook P., Wood M. J. Successors to acyclovir. J. Antimicrob. Chemother. 34:1994;307-311.
54. Edery I., Petryshyn R., Sonenberg N. Activation of double-stranded RNA-dependent kinase (dsI) by the TAR region of HIV-1 mRNA. a novel translation control mechanism Cell. 56:1989;303-312.
55. Elia A., Laing K. G., Schofield A., Tilleray V. J., Clemens M. J. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucl. Acids Res. 24:1996;4471-4478.
56. Eloit M., Adam M., Fournier A. High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring VAI genes. J. Virol. 71:1997;5375-5381.
57. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. sensitivity to interferon is conferred by amino acid substitutions in the NS5A region J. Clin. Invest. 96:1995;224-230.
58. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Ogura Y., Izumi N., Maruno F., Sato C. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334:1996;77-81.
59. Feng G. S., Chong K. L., Kumara A., Williams B. R. G. Identification of dsRNA binding domains in the interferon-induced dsRNA-activated P68 kinase. Proc. Natl. Acad. Sci. USA. 89:1992;5447-5451.
60. Francis M. L., Meltzer M. S., Gendelman H. E. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res. Hum. Retroviruses. 8:1992;199-207.
61. Fried M., Hoofnagle J. Therapy of hepatitis C. Semin. Liver Dis. 15:1995;82-91.
62. Galabru J., Katze M. G., Robert N., Hovanessian A. G. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur. J. Biochem. 178:1989;581-589.
63. IPK and vaccinia virus K3L is mediated by unique domains. implications for kinase regulation Mol. Cell. Biol. 16:1996;4172-4181.
64. Gale M. Jr., Korth M. J., Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 230:1997;217-227.
65. r IPK Mol. Cell. Biol. 18:1998;859-871.
66. Gatignol A., Buckler-White A., Berkhout B., Jeang K. T. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science. 251:1991;1597-1600.
67. Gatignol A., Buckler C., Jeang K.-T. Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol. Cell. Biol. 13:1993;2193-2202.
68. Ghadge G., Swaminathan S., Katze M. G., Thimmappaya B. Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function. Proc. Natl. Acad. Sci. USA. 88:1991;7140-7144.
69. Giantini M., Shatkin A. Stimulation of chloramphenicol acetyl transferase mRNA translation by reovirus capsid polypeptide sigma 3 in cotransfected Cos cells. J. Virol. 63:1989;2415-2421.
70. Goebel S. J., Johnson G. P., Perkus M. E., Davis S. W., Winslow J. P., Paoletti E. The complete sequence of vaccinia virus. Virology. 179:1990;247-266.
71. Goebl M., Yanagida M. The TPR snap helix. a novel protein repeat motif from mitosis to transcription Trends Biochem. Sci. 16:1991;173-177.
72. Green S. R., Mathews M. B. Two RNA binding motifs in the double-stranded RNA activated protein kinase, DAI. Genes Dev. 6:1992;2478-2490.
73. Gunnery S. A., Rice P., Robertson H. D., Mathews M. B. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 87:1990;8687-8691.
74. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family. conserved features and deduced phylogeny of the catalytic domains Science. 241:1988;42-52.
75. Hatada E., Fukuda R. Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73:1992;3325-3329.
76. - herpes simplex virus 1. failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the a47 gene J. Virol. 71:1997;6049-6054. a.
77. He B., Gross M., Roizman B. The γ4.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;843-848. b.
78. Hickey E., Brandon S. E., Smale G., Lloyd D., Weber L. A. Sequence and regulation of a gene encoding a human 89 kilodalton heat shock protein. Mol. Cell. Biol. 9:1989;2615-2626.
79. Hinnebusch A. G. The eIF-2α kinases. regulators of protein synthesis in starvation and stress Semin. Cell Biol. 5:1994;417-426.
80. Ho C.-K., Shuman S. Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J. Virol. 70:1996;2611-2614. a.
81. Ho C.-K., Shuman S. Physical and functional characterization of the double-stranded RNA binding protein encoded by the vaccinia virus E3 gene. Virology. 217:1996;272-284. b.
82. Hoofnagle J. H. Therapy of acute and chronic viral hepatitis. Adv. Intern. Med. 39:1994;241-275.
83. Huismans H., Joklik W. K. Reovirus-coded polypeptides in infected cells. isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively Virology. 70:1976;411-424.
84. Icely P. L., Gros P., Bergeron J. J. M., Devault A., Afar D. E. H., Bell J. C. TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine. J. Biol. Chem. 266:1991;16073-16077.
85. Iino S., Hino K., Yasuda K. Current state of interferon therapy for chronic hepatitis C. Intervirology. 37:1994;87-100.
86. Imani F., Jacobs B. L. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA. 85:1988;7887-7891.
87. Jacobs B. L., Ferguson R. E. The Lang strain of reovirus serotype 1 and the Dearing strain of reovirus serotype 3 differ in their sensitivities to beta interferon. J. Virol. 65:1991;5102-5104.
88. Jaramillo M. L., Abraham N., Bell J. C. The interferon system. a review with emphasis on the role of PKR in growth control Cancer Invest. 13:1995;327-338.
89. I in adenovirus-2-infected HeLa cells. J. Cell Sci. 106:1993;11-22.
90. Johnston D., Brown N. H., Gall J. G., Jantsch M. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA. 89:1992;10979-10983.
91. r protein kinase Semin. Virol. 4:1993;259-268.
92. Katze M. G. Regulation of the interferon-induced PKR. can viruses cope? Trends Microbiol. 3:1995;75-78.
93. Katze, M. G. (1996) Translational control in cells infected with influenza virus and reovirus. In: Translational Control, pp. 607-630, Hershey, J. W. B., Mathews, M. B. and Sonenberg, N. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
94. Katze M. G., Agy M. B. The regulation of viral and cellular RNA turnover in cells infected by eukaryotic viruses including human immunodeficiency virus, HIV-1. Enzyme. 44:1990;332-346.
95. r protein kinase to regulate its autophosphorylation and activity. EMBO J. 6:1987;689-697.
96. Katze M. G., Tomita J., Black T., Krug R. M., Safer B., Hovanessian A. G. Influenza virus regulates protein synthesis during infection by repressing the autophosphorylation and activity of the cellular 68,000 Mr protein kinase. J. Virol. 62:1988;3710-3717.
97. Katze M. G., Wambach M., Wong M.-L., Garfinkel M. S., Meurs E., Chong K. L., Williams B. R. G., Hovanessian A. G., Barber G. N. Functional expression of interferon-induced, dsRNA activated 68,000 Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11:1991;5497-5505.
98. Kaufman R. J., Davies M. V., Pathak V. K., Hershey J. W. B. The phosphorylation state of eukaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell. Biol. 9:1989;946-958.
99. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T. W., Taniguchi T. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
100. Kirchhoff S., Koromilas A. E., Schaper F., Grashof M., Sonenberg N., Hauser H. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene. 11:1995;439-445.
101. Kitajewski J., Schneider R. J., Safer B., Munemitsu S. M., Samuel C. E., Thimmappaya B., Shenk T. Adenovirus VAI RNA antagonizes the antiviral action of the interferon-induced eIF-2 alpha kinase. Cell. 45:1986;195-200.
102. Kobayashi M., Locke E., Silverman J., Ung T., Dever T. E. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF-2α Mol. Cell. Biol. 17:1997;4146-4158.
103. Kolykhalov A. A., Agapov E. V., Blight K. J., Mihalik K., Feinstone S. M., Rice C. M. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science. 277:1997;570-574.
104. Koromilas A. E., Cantin C., Craig A. W. B., Jagus R., Hiscott J., Sonenberg N. The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J. Biol. Chem. 270:1995;25426-25434.
105. Korth M. J., Lyons C. N., Wambach M., Katze M. G. Cloning, expression, and cellular localization of the oncogenic 58-kDa inhibitor of the RNA-activated human and mouse protein kinase. Gene. 170:1996;181-188.
106. Krug R. M., Shaw M., Broni B., Shapiro G., Haller O. Inhibition of influenza viral messenger RNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 56:1985;201-206.
107. Krug, R. M., Alonso-Caplen, F., Julkunen, I. and Katze, M. G. (1989) Expression and replication of the influenza virus genome. In: Influenza Viruses, 77th edn., pp. 89-152, Krug, R. M. (ed.) Plenum Publishing Co., New York.
108. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B. R. G. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA. 91:1994;6288-6292.
109. Kumar A., Yang Y., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissmann C., Williams B. R. G. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene. role of IRF-1 and NF-κB EMBO J. 16:1997;406-413.
110. Lamb J. R., Tugendreich S., Hieter P. Tetratricopeptide repeat interactions. to TPR or not to TPR? Trends Biochem. Sci. 20:1995;257-259.
111. Lamb R. A., Horvath C. M. Diversity of coding strategies in influenza viruses. Trends Genet. 7:1991;261-266.
112. r=66,000 dalton subunits. J. Biol. Chem. 267:1992;10729-10736.
113. Laurence J. Immunology of HIV infection, I. biology of interferons AIDS Res. Hum. Retroviruses. 6:1990;1149-1156.
114. Lee S. B., Esteban M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology. 199:1994;491-496.
115. Lee S. B., Rodriguez D., Rodriguez J. R., Esteban M. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream from Bcl-2, and involves ICE-like proteases. Virology. 231:1997;81-88.
116. Lee T.-G., Katze M. G. Cellular inhibitors of the interferon-induced, dsRNA-activated protein kinase. Prog. Mol. Subcell. Biol. 14:1993;48-65.
117. r protein kinase from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA. 87:1990;6208-6212.
118. Lee T. G., Tomita J., Hovanessian A. G., Katze M. G. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J. Biol. Chem. 267:1992;14238-14243.
119. Lee T. G., Tang N., Thompson S., Miller J., Katze M. G. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14:1994;2331-2342.
120. Lemay G., Millward S. Expression of the cloned S4 gene of reovirus serotype 3 in transformed eucaryotic cells. enrichment of the viral protein in the crude initiation factor fraction Virus Res. 6:1986;133-140.
121. Lemieux R., Lemay G., Millward S. The viral protein sigma 3 participates in translation of late viral mRNA in reovirus-infected L cells. J. Virol. 61:1987;2472-2479.
122. Lenardo M. J., Fan C. M., Maniatis T., Baltimore D. The involvement of NF-κB in β-interferon gene regulation reveals its role as a widely inducible mediator of signal transduction. Cell. 57:1989;287-294.
123. Li J., Petryshyn R. A. Activation of the double-stranded RNA-dependent eIF-2α kinase by cellular RNA from 3T3-F442A cells. Eur. J. Biochem. 195:1991;41-48.
124. Lloyd R. M., Shatkin A. J. Translational stimulation by reovirus polypeptide 3. substitution for VAI RNA and inhibition of phosphorylation of the α subunit of eukaryotic initiation factor 2 J. Virol. 66:1992;6878-6884.
125. Lockhart D. J., Dong H., Byrne M. C., Follettie M. T., Gallo M. V., Chee M. S., Mittmann M., Wang C., Kobayashi M., Horton H. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotech. 14:1996;1675-1680.
126. Lu Y., Wambach M., Katze M. G., Krug R. M. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology. 214:1995;222-228.
127. Ma Y., Mathews M. B. Secondary and tertiary structure in the central domain of adenovirus type 2 VAI RNA. RNA. 2:1996;937-955.
128. Maitra R. K., McMillan N., Desai S., McSwiggen J., Hovanessian A. G., Sen G., Williams B. R. G., Silverman R. H. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 204:1994;823-827.
129. Manche L., Green S. R., Schmedt C., Mathews M. B. Interactions between dsRNA regulators and the protein kinase, DAI. Mol. Cell. Biol. 12:1992;5238-5248.
130. Maran A., Mathews M. B. Characterization of the dsRNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA 1. Virology. 164:1988;106-113.
131. Maran A., Maitra R. K., Kumar A., Dong B., Xiao W., Li G., Williams B. R. G., Torrence P. F., Silverman R. H. Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science. 265:1994;789-792.
132. Mathews M. B. Viral evasion of cellular defense mechanisms. regulation of the protein kinase DAI by RNA effectors Semin. Virol. 4:1993;507.1-507.12.
133. Mathews M. B. Viral evasion of cellular defense mechanisms. regulation of the protein kinase DAI by RNA effectors Semin. Virol. 4:1995;247-257.
134. Mathews, M. B. (1996) Interactions between viruses and the cellular machinery for protein synthesis. In: Translational Control, pp. 505-548, Hershey, J., Mathews, M. B. and Sonenberg, N. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
135. Mathews M. B., Shenk T. Control of translation in adenovirus-infected cells. Enzyme. 44:1990;250-264.
136. Mathews M. B., Shenk T. Adenovirus virus-associated RNA and translation control. J. Virol. 65:1991;5657-5662.
137. l and TAR RNAs Virology. 206:1995;511-519.
138. McCrae M. A., Joklik W. K. The nature of the polypeptide encoded by each of the 10 double-stranded RNA segments of reovirus type 3. Virology. 89:1978;578-593.
139. McMillan N. A. J., Chun R. F., Siderovski D. P., Galabru J., Toone W. M., Samuel C. E., Mak T. W., Hovanessian A. G., Jeang K.-T., Williams B. R. G. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology. 213:1995;413-424.
140. 1 with the protein kinase DAI. nonequivalence of binding and function Cell. 61:1990;843-852.
141. IPK, the cellular inhibitor of PKR. Proc. Natl. Acad. Sci. USA. 94:1997;97-102.
142. Merrick, W. C. and Hershey, J. W. B. (1996) The pathway and mechanism of eukaryotic protein synthesis. In: Translational Control, pp. 31-70, Hershey, J., Mathews, M. B. and Sonenberg, N. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
143. Meurs E., Chong K. L., Galabru J., Thomas N., Kerr I., Williams B. R. G., Hovanessian A. G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:1990;379-390.
144. Meurs E., Galabru J., Barber G. N., Katze M. G., Hovanessian A. G. Tumour suppressor function of the interferon-induced double-stranded RNA-activated 68,000-Mr protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;232-236.
145. Meylan P. R. A., Guatelli J. C., Munis J. R., Richman D. D., Kornbluth R. S. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology. 193:1993;138-148.
146. Miller J. E., Samuel C. E. Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity. identification of a repeated basic amino acid motif within the C-terminal binding region J. Virol. 66:1992;5347-5356.
147. Mohr I., Gluzman Y. A herpes virus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15:1996;4759-4766.
148. Morimoto, R. I., Tissieres, A. and Georgopoulos, C. (1994) Progress and perspectives on the biology of heat shock proteins and molecular chaperones. In: The Biology of Heat Shock Proteins and Molecular Chaperones, pp. 1-30, Morimoto, R. I., Tissieres, A. and Georgopoulos, C. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
149. Muller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1924.
150. Mundschau L. J., Faller D. V. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. J. Biol. Chem. 270:1995;3100-3106.
151. O'Malley R. P., Mariano T. M., Siekierka J., Mathews M. B. A mechanism for the control of protein synthesis by adenovirus VA RNA. Cell. 44:1994;391-400.
152. Ortega L. G., McCotter M. D., Henry G. L., McCormack S. J., Thomis D. C., Samuel C. E. Mechanism of interferon action. biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells Virology. 215:1996;31-39.
153. Park H., Davies M. V., Langland J. O., Chang H.-W., Nam Y. S., Tartaglia J., Paoletti E., Jacobs B. L., Kaufman R. J., Venkatesan S. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. USA. 91:1994;4713-4717.
154. Patel R., Sen G. C. Identification of the double stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267:1992;7871-7876.
155. Patel R. C., Stanton P., McMillan N. M. J., Williams B. R. G., Sen G. C. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;8283-8287.
156. Patel R. C., Stanton P., Sen G. C. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271:1996;25657-25663.
157. Pavlovic J., Staehli P. The antiviral potentials of Mx proteins. J. Interferon Res. 11:1991;215-219.
158. Pestka S., Langer J. A., Zoon K., Samuel C. E. Interferons and their actions. Annu. Rev. Biochem. 56:1987;727-777.
159. Petryshyn R. A., Ferrenz A. G., Li J. Characterization and mapping of the double-stranded regions involved in activation of PKR within a cellular RNA from 3T3-F442A cells. Nucl. Acids Res. 25:1997;2672-2678.
160. Pitha P. Multiple effects of interferon on HIV-1 replication. J. Interferon Res. 11:1991;313-318.
161. Poli G., Orenstein J. M., Kinter A., Folks T. M., Fauci A. S. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 244:1989;575-577.
162. Polyak S. J., Tang N., Wambach M., Barber G. N., Katze M. G. The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity. J. Biol. Chem. 271:1996;1702-1707.
163. 134.5 genes of herpes simplex virus. Virology. 229:1997;98-105.
164. Proud C. G. PKR. a new name and new roles Trends Biochem. Sci. 20:1995;241-246.
165. Qiu Y., Krug R. M. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68:1994;2425-2432.
166. Raabe T., Manley J. L. A human homologue of the Escherichia coli DnaJ heat-shock protein. Nucl. Acids Res. 19:1991;6445.
167. Rajan P., Swaminathan S., Zhu J., Cole C. N., Barber G., Tevethia M. J., Thimmapaya B. A novel translational regulation function for the simian virus 40 large T-antigen gene. J. Virol. 69:1995;785-795.
168. 1 regulates the activity of a protein synthesis initiator factor. Nature. 313:1985;196-200.
169. Robertson H. D., Manche L., Mathews M. B. Paradoxical interactions between human delta hepatitis agent RNA and the cellular protein kinase PKR. J. Virol. 70:1996;5611-5617.
170. Romano P. R., Green S. R., Barber G. N., Mathews M. B., Hinnebusch A. G. Structural requirements for dsRNA-binding, dimerization and activation of the human eIF-2α kinase DAI in yeast. Mol. Cell. Biol. 15:1995;365-378.
171. Roy S., Katze M. G., Parkin N. T., Edery I., Hovanessian A. G., Sonenberg N. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science. 247:1990;1216-1219.
172. r protein kinase. J. Virol. 65:1991;632-640.
173. Samuel C. E. Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
174. Samuel C. E. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268:1993;7603-7606.
175. Schiff L. A., Nibert M. L., Co M. S., Brown E. G., Fields B. N. Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein σ3. Mol. Cell. Biol. 8:1988;273-283.
176. Schmechel S., Chute M., Skinner P., Anderson R., Schiff L. Preferential translation of reovirus mRNA by a σ3-dependent mechanism. Virology. 232:1997;62-73.
177. Schneider, R. J. (1996) Adenovirus and vaccinia virus translational control. In: Translational Control, pp. 575-606, Hershey, J., Mathews, M. B. and Sonenberg, N. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
178. Seliger L. S., Giantini M., Shatkin A. J. Translational effects and sequence comparisons of the three serotypes of the reovirus S4 gene. Virology. 187:1992;202-210.
179. Sen G. C., Lengyel P. The interferon system. a bird's eye view of its biochemistry J. Biol. Chem. 267:1992;5017-5020.
180. Sen G. C., Ransohoff R. M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:1993;57.
181. l RNA. Nucl. Acids Res. 21:1993;4483-4490.
182. Sharpe A. H., Fields B. N. Reovirus inhibition of cellular RNA and protein synthesis. role of the S4 gene Virology. 122:1982;381-391.
183. Siekierka J., Mariano T. M., Reichel P. A., Mathews M. B. Translational control by adenovirus. lack of virus-associated RNA1 during adenovirus infection results in phosphorylation of initiation factor elF-2 and inhibition of protein synthesis Proc. Natl. Acad. Sci. USA. 82:1985;1959-1963.
184. Silver P. A., Way J. C. Eukaryotic DnaJ homologs and the specificity of Hsp70 activity. Cell. 74:1993;5-6.
185. Silverman R. H. Fascination with 2-5A-dependent RNase. a unique enzyme that functions in interferon action J. Interferon Res. 14:1994;101-104.
186. nA system in HeLa cells. effects of interferon and virus infection Eur. J. Biochem. 124:1982;131-138.
187. Song Q., Khanna K. K., Lu H., Lavin M. F. Cloning and characterization of a human protein phosphatase 1-encoding cDNA. Gene. 129:1993;291-295.
188. Sperber S. J., Gocke D. J., Haberzettl C., Kuk R., Schwartz B., Pestka S. Anti-HIV-1 activity of recombinant and hybrid species of interferon alpha. J. Interferon Res. 12:1992;363-368.
189. Srivastava S. P., Davies M. V., Kaufman R. J. Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis. J. Biol. Chem. 270:1995;16619-16624.
190. Staehli P. Interferon induced proteins and the antiviral state. Adv. Virus Res. 38:1990;147-200.
191. Swaminathan S., Huneycutt B. S., Reiss C. S., Kieff E. Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes. J. Virol. 66:1992;5133-5136.
192. Swaminathan S., Rajan P., Savinova O., Jagus R., Thimmapaya B. Simian virus 40 bypasses the translational block imposed by the phosphorylation of eIF-2α Virology. 219:1996;321-323.
193. IPK prevents dimerization of the interferon-induced, dsRNA-activated protein kinase: implications for kinase modulation and Dna J domain function. Mol. Cell. Biol., in press.
194. Tanaka H., Samuel C. E. Mechanism of interferon action. structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase Proc. Natl. Acad. Sci. USA. 91:1994;7995-7999.
195. Taylor D. R., Lee S. B., Romano P. R., Marshak D. R., Hinnebusch A. G., Esteban M., Mathews M. B. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol. Cell. Biol. 16:1996;6295-6302.
196. Taylor S. S., Knighton D. R., Zheng J., Sowadski J. M., Gibbs C. S., Zoller M. J. A template for the protein kinase family. Trends Biochem. Sci. 18:1993;84-89.
197. Thimmappaya B., Weinberger C., Schneider R. J., Shenk T. Adenovirus VA1 RNA is required for efficient translation of viral mRNAs at late times after infection. Cell. 31:1982;543-551.
198. Thomis D. C., Samuel C. E. Mechanism of interferon action. characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase J. Virol. 69:1995;5195-5198.
199. Thomis D. C., Doohan J. P., Samuel C. E. Mechanism of interferon action. cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2α protein kinase from human cells Virology. 188:1992;33-46.
200. Tillotson L., Shatkin A. J. Reovirus polypeptide σ3 and N-terminal myristoylation of polypeptide μ1are required for site-specific cleavage to μ1C in transfected cells. J. Virol. 66:1992;2180-2186.
201. Watson J. C., Chang H.-W., Jacobs B. L. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology. 185:1991;206-216.
202. Whitaker-Dowling P. A., Younger J. S. Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase activity. Virology. 137:1984;171-181.
203. Williams B. R. G. The role of the dsRNA-activated kinase, PKR, in signal transduction. Semin. Virol. 6:1995;191-202.
204. Yang Y.-L., Reis L. F. L., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B. R. G., Ague M., Weissmann C. Deficient signalling in mice devoid of double-stranded RNA-dependent protein kinase, PKR. EMBO J. 14:1995;6095-6106.
205. Yeung M. C., Liu J., Lau A. S. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. USA. 93:1996;12451-12455.
206. Yue Z., Shatkin A. J. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology. 234:1997;364-371. a.
207. Yue Z., Shatkin A. J. Regulated, stable expression and nuclear presence of reovirus double-stranded RNA-binding protein σ3 in hela cells. J. Virol. 70:1997;3497-3501. b.
208. Zhan Q., Lord K. A., Alamo I. Jr., Hollander M. C., Carrier F., Ron D., Kohn K. W., Hoffman B., Lieberman D. A., Fornance A. J. Jr. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol. 14:1994;2361-2371.
209. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2′-5′ A-dependent RNAase. a uniquely regulated mediator of interferon action Cell. 72:1993;753-765.
210. Zhu S., Romano P. R., Wek R. C. Ribosome targeting of PKR is mediated by two double-stranded RNA-binding domains and facilitates in vivo phosphorylation of eukaryotic initiation factor-2. J. Biol. Chem. 272:1997;14434-14441.
211. Zweerink H. J., Joklik W. K. Studies on the intercellular synthesis of reovirus-specified proteins. Virology. 44:1970;501-518.